Status:
RECRUITING
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Collaborating Sponsors:
Conquer Cancer Foundation
Conditions:
Lung Cancers
Gastrointestinal Cancers
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot study will evaluate whether an intervention aimed at hospitalized patients with advanced lung and gastrointestinal cancers can help facilitate goals-of-care (GOC) communication with their o...
Eligibility Criteria
Inclusion
- Unplanned admission to the HUP Solid Oncology service;
- Underlying diagnosis of advanced lung or GI cancer, defined as metastatic or locally advanced disease;
- Anticipated discharge within the next 72h; and
- Primary oncologist is based at HUP; or
- Family member/caregiver of a patient meeting the above 4 criteria.
Exclusion
- 1\. Unable to complete survey in English.
Key Trial Info
Start Date :
July 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06955468
Start Date
July 21 2025
End Date
May 1 2026
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104